Background While the evidence for the clinical effectiveness of most noncommunicable
disease (NCD) prevention and treatment interventions is well established, care delivery …

Background: Disparities in the availability of reperfusion services for acute ischemic stroke
are considerable globally and require urgent attention. Contemporary data on the …

Stroke is one of the leading causes of mortality globally and a main cause of disability. The
objective of this study was to evaluate the importance and utility of the Alberta Stroke …

Baicalin (BA) is widely used in the treatment of cerebral ischemia-reperfusion injury (CIRI).
The key to treating encephalopathy is to increase the amounts of drugs entering the brain …

Background: The standard reperfusion therapy for acute ischemic stroke (AIS) is considered
to be thrombolysis, but its application is limited by the high risk of hemorrhagic …

Stroke is a significant disability and death cause worldwide and is conventionally defined as
a neurological impairment relating to the intense focal harm of the central nervous system …

Introduction: Stroke is the second leading cause of death worldwide and Romania is no
exception. There is a high economic burden associated with the treatment of stroke patients …

Background and objectives: Although the intravenous tissue plasminogen activator (rt-PA)
has been shown to be effective in the treatment of acute ischemic stroke (AIS), only a small …

Little information has been compiled across studies about existing interventions to mitigate
issues of medical financial hardship, despite growing interest in health care delivery. The …

Introduction: Ischemic stroke (IS) is one of the three main fatal disorders and is a major
health challenge. 4-methylumbelliferone (4-MU) is one of the coumarin derivatives (7 …